Resonant Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Resonant Capital Advisors's AMGN Position: Q2 2026 in Review
Resonant Capital Advisors increased its Amgen (AMGN) stake by 3.6% in Q2 2026, buying an estimated $186K and bringing the position to 15,803 shares worth $5.72M. The position accounts for 0.27% of the portfolio, ranked #64.
Resonant Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Resonant Capital Advisors held 15,803 shares of Amgen worth $5.72M as of Q2 2026.
- Resonant Capital Advisors bought 542 Amgen shares in Q2 2026, an estimated $186K.
- Amgen made up 0.27% of Resonant Capital Advisors's portfolio in Q2 2026, its #64 holding.
- Resonant Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.